Tekedia · May 2026
Tekedia Capital announced its investment in Exonic and described the company as building biological foundation models across noisy, unstructured life-science data.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Exonic (Exonic Biosciences Inc.) is a YC F25 biotechnology research startup building Exonic Studio, a crowdsourced, no-code biological AI platform for precision gene therapy and synthetic enhancer design. Public sources describe it as open-source, lab-validated, and tournament-based, with a small San Francisco team and early-stage funding.
Primary product
Exonic Studio, an AI-driven crowdsourced drug discovery and synthetic biology platform for designing and wet-lab testing DNA sequences and gene-therapy workflows
Founded
2025
Headquarters
San Francisco, California, United States
Team size
1-10 employees
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
Open Positions
0 jobs at Exonic
No open positions
Check back later for new openings